| ||
| Peregrine reports promising Phase ll data in non-small cell lung ... Peregrine says lung cancer drug extended survival - AP; Peregrine reports promising Phase ll data in non-small cell lung cancer study - theflyonthewall. com ... finance.yahoo.com/.../Peregrine-reports-promising-theflyonth... | ||
| Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung These studies show that FGFR1 amplification is common in squamous cell lung cancer, and that FGFR1 may represent a promising therapeutic target in non-small ... www.ncbi.nlm.nih.gov/pmc/articles/PMC3110189/ |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment